
词语导航
基本信息
词语:尿沙
繁体:尿沙
拼音:niào shā
英语翻译
【医】 arena; gravel; psamma; urocheras; uropsammus
相关词条
1.urinarysand 2.psamma 3.uropsammus分词翻译
尿的英语翻译:
make water; stale; urine【医】 ur-; urina; urine; urino-; uro-; urono-
沙的英语翻译:
hoarse; powdered; sand【医】 ammo-; micromicro-; pico-; psammo-; sand
翻译例句
1. 感染拉沙病毒的Mastomys 鼠并不发病,但它们可将病毒排放到其排泄物(尿和粪便)中。
Mastomys infected with Lassa virus do not become ill, but they can shed the virus in their excreta (urine and faeces).
2. 目的我们研究直接肾素抑制剂阿利吉仑的抗蛋白尿作用是否与依贝沙坦相当及两者联合的效果。
OBJECTIVE We investigated whether the antiproteinuric effect of the direct renin inhibitor aliskiren is comparable to that of irbesartan and the effect of the combination.
3. 结论:奥美沙坦与微量蛋白尿延缓出现有关,尽管基于现行标准,两组患者的血压控制情况均较好。
CONCLUSIONS: Olmesartan was associated with a delayed onset of microalbuminuria, even though blood-pressure control in both groups was excellent according to current standards.
4. 我们比较了最大推荐剂量的阿利吉仑、依贝沙坦及两者联合应用在2型糖尿病和蛋白尿患者的抗蛋白尿作用。
We compared the antiproteinuric effect of maximal recommended doses of aliskiren, irbesartan, and the combination in patients with type 2 diabetes and albuminuria.
5. 目的:观察伊贝沙坦对良性小动脉性肾硬化蛋白尿的效应。
Objective: To observe the effect of irbesartan on proteinuria in benign arteriolar nephrosclerosis patients.
6. 目的观察低分子肝素联合缬沙坦对2型早期糖尿病肾病(DN)患者尿白蛋白排泄率(UAER)的影响。
Objective To investigate the impact of low molecular heparin(LMH)and valsartan on urine albumin excretion rate(UAER)in patients with early type-2 diabetic nephropathy(DN).
7. 目的观察在微量白蛋白尿发生前后应用氯沙坦对糖尿病肾病(DN)的治疗作用及其机制。
Objective To estimate the therapeutical effect and mechanism of losartan on diabetic nephropathy (DN) before and after microalbuminuria.
8. 目的探讨氯沙坦治疗轻、中度原发性高血压的疗效和对尿清蛋白的影响。
Objective To investigate the efficacy and antiproteinuric effect of losartan in the treatment of mild to moderate essential hypertension.
9. 结论:伴或不伴双氢克尿噻,低钠饮食时,AER对替米沙坦的反应会被补钠减弱。
CONCLUSIONS The AER response to telmisartan with or without HCT under habitual low salt intake can be blunted by NaCl supplementation.
10. 此外,ROADMAP数据证明奥美沙坦可预防2型糖尿病患者发生微量白蛋白尿(mau)。
In addition, data from ROADMAP proved that olmesartan can reduce risk of microalbuminuria (MAU) in Type 2 diabetes (T2DM) patients.
11. 目的:建立洛美沙星人血浆及尿药浓度HPLC柱切换测定法。
OBJECTIVE:To establish a simple HPLC column switching method for measuring lomefloxacin in human plasma and urine.
12. 目的观察比较缬沙坦与硝苯地平对于高血压患者白蛋白尿及肾功能的疗效。
Objective To study the effects of valsartan and nifedipine on proteinuria and renal function of patients with hypertension.Www.weNtIYI.COm
13. 结果缬沙坦治疗组较糖尿病非治疗组尿白蛋白排泄量明显减少(P<001),血肌酐水平下降(P<005),肾脏肥大指标改善(P<005)。
Results Serum creatinine level ( Purinary albumin excretion and kidney hypertrophy index ( Ptreated group were significantly lower than those of diabetic untreated group.
14. Bilou教授:根据我们现有的数据,就像今天汇报的那样,还不能说坎地沙坦(Candesatan)对微量白蛋白尿的一级预防是有用的。
Prof. R. W. Bilou: Well, at the moment from our data as presented today we can"t say that Candesatan has a role for the primary prevention of microalbuminuria.
15. 氯沙坦可以减轻雷帕霉素所致的大量蛋白尿。
Furthermore, losartan can alleviate severe proteinuria induced by rapamycin.
16. 结论:替米沙坦减轻糖尿病肾病患者蛋白尿优于氯沙坦。
CONCLUSION Telmisartan is superior to losartan in reducing proteinuria in diabetic nephropathy patients with hypertension, despite a similar reduction in blood pressure.
17. 但之后统计的数据均提示,奥美沙坦组出现微量白蛋白尿的患者少于安慰剂组。
For the remainder of the study, fewer patients in the olmesartan group experienced microalbuminuria, compared with patients in the placebo group.
18. 这意味着与安慰剂组相比,奥美沙坦组出现微量白蛋白尿的风险降低了23%。
This translated into a risk reduction of 23% for the olmesartan group, compared with the placebo group.
19. 这意味着与安慰剂组相比,奥美沙坦组出现微量白蛋白尿的风险降低了23%。
This translated into a risk reduction of 23% for the olmesartan group, compared with the placebo group.
版权声明:问题易所有作品(图文、音视频)均来源网络,版权归原创作者所有,与本站立场无关,如不慎侵犯了你的权益,请联系我们告知,我们将做删除处理!
